Division of Pharmaceutics, College of Pharmacy, the University of Texas at Austin, 2409 University Avenue, A1920, Austin, Texas, 78712, USA.
Department of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, 2409 University Avenue, A1920, Austin, Texas, 78712, USA.
AAPS PharmSciTech. 2018 Apr;19(3):978-990. doi: 10.1208/s12249-018-0953-z. Epub 2018 Jan 16.
The understanding of amorphous solid dispersions has grown significantly in the past decade. This is evident from the number of approved commercial amorphous solid dispersion products. While amorphous formulation is considered an enabling technology, it has become the norm for formulating poorly soluble compounds. Despite this success, improvements can still be made that enable early development formulation decisions, to develop a rationale for selecting a manufacturing process, to overcome degradation and phase separation during processing, to help achieve physical stability during storage, and to optimize dissolution behavior. The purpose of this literature review is to present recently reported strategies for improving the development and performance of ASDs. The benefits and limitations of each strategy as well as recent relevant case studies will be presented in this review. The strategies are presented from three different aspects: (a) prediction techniques that enable formulation decisions, (b) manufacturing considerations that help produce physically and chemically stable ASDs, and
在过去的十年中,人们对无定形固体分散体的理解有了显著的提高。这从获得批准的商业无定形固体分散体产品的数量就可以看出来。虽然无定形制剂被认为是一种使能技术,但它已经成为了一种常规的方法,用于制备难溶性化合物。尽管取得了这一成功,但仍可以进行改进,以便能够在早期开发阶段做出制剂决策,为选择制造工艺提供依据,克服加工过程中的降解和相分离,帮助在储存过程中实现物理稳定性,并优化溶解行为。本文综述的目的是介绍最近报道的改善 ASDs 开发和性能的策略。本文将介绍每种策略的优缺点以及最近的相关案例研究。这些策略从三个不同的方面进行介绍:(a)能够做出制剂决策的预测技术,(b)有助于生产物理和化学稳定的 ASDs 的制造考虑因素,以及